Phase I Study: Electroporation Therapy With Bleomycin For The Treatment Of Pancreatic Cancer.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2012
At a glance
- Drugs Bleomycin (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Sep 2012 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 17 Sep 2005 New trial record.